1. Prevalence of dyslipidemia and its control in type 2 diabetes: A multicenter study in endocrinology clinics of China
- Author
-
Ming Tong Xu, Xing Wu Ran, Yong Jian Wang, Ling Gao, Peng Hua Wang, Jian Huang Fu, Wei-Qing Chen, Yan Jun Wang, Bing Chen, Guang Ning, Zhang Rong Xu, Li Yan, Miao Zhang, Yu Duan, Qing Hua Guo, Wei Qing Wang, You Min Wang, Qiang Li, Wei Gang Zhao, Li Yuan, Zhen Fang Yuan, Hua Zhang Yang, and Zuo Jie Luo
- Subjects
Adult ,Male ,medicine.medical_specialty ,China ,Health Knowledge, Attitudes, Practice ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Type 2 diabetes ,Disease ,030204 cardiovascular system & hematology ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Internal medicine ,Internal Medicine ,Prevalence ,Medicine ,Humans ,Cities ,Lipoprotein cholesterol ,Dyslipidemias ,Nutrition and Dietetics ,business.industry ,Serum lipid levels ,nutritional and metabolic diseases ,Chinese adults ,Type 2 Diabetes Mellitus ,Middle Aged ,medicine.disease ,Hospitals ,Cross-Sectional Studies ,Multicenter study ,Diabetes Mellitus, Type 2 ,Female ,Cardiology and Cardiovascular Medicine ,business ,Dyslipidemia - Abstract
Objective The aim of this study was to assess the levels of serum lipid and awareness, treatment, and control of dyslipidemia in type 2 diabetes mellitus (T2DM) patients from top-ranked endocrinology clinics in large cities of China. Materials and Methods A cross-sectional study in a representative sample of 4807 Chinese adults 40 to 75 years of age was conducted during 2010 to 2011 at 20 endocrinology clinics in top-ranked hospitals covering most of the major cities of China. Serum lipid levels were measured, and treatment of dyslipidemia was recorded and assessed. Results In the present study, the prevalence of dyslipidemia was 67.1% in T2DM subjects. Among those with dyslipidemia, the proportion of awareness and treatment was 68.7% and 55.9%. Among participants with lipid-lowering therapy, 686 subjects achieved the low-density lipoprotein cholesterol (LDL-C) control less than 2.60 mmol/L, with the rate being 39.4%. In those patients with previous cardiovascular disease, the percentage of participants who achieved LDL-C goal (1.80 mmol/L) was 15.3%. Conclusion The prevalence of dyslipidemia is high, and the awareness, treatment, and control of dyslipidemia are relatively low in Chinese T2DM patients. This calls for the awareness and intervention of dyslipidemia in these patients.
- Published
- 2015